ABSTRACT

Peripheral arterial disease (PAH) is a common cardiovascular disease. PAH treatments are long-term treatments that target the control of risk factors. Endovascular treatment is considered a more comfortable option compared to surgery. In recent years, increasing evidence has emerged about the efficacy of endovascular treatment modalities. This study investigates the effect of device diameter on endovascular treatment outcomes in PAH.

In this retrospective cohort study, endovascular interventions on 100 patients were evaluated. The collected data was anonymized before being transferred to an electronic database for analysis. SPSS 26.0 was used for statistical analysis; chi-square, Fisher’s exact test and phi-crammer tests were used for categorical variables, while F-ANOVA test was used for continuous variables.

Based on the study’s findings, no significant difference was observed between the change in device diameter and factors such as female gender, age, coronary artery disease, hypertension, type 2 diabetes, and tobacco use. However, the rate of stenosis varied between different groups. Furthermore, there was no significant difference in outcomes between the use of drug-coated balloon angioplasty and bare metal stent applications. Both technical success rates and hemodynamic success rates were consistently high across all groups, with no statistically significant differences between them. Similarly, the primary patency rates remained notably high during both the 30-day and 6-month follow-up periods, showing no statistically significant variation.

This study evaluated the effect of device diameter on endovascular treatment outcomes in PAH. Device diameters did not have any effect on revascularization, the results were high and promising in all groups. However, the limitations of the study and the lack of a randomized controlled design should be considered. Therefore, prospective studies with larger patient groups are needed.